Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia

BACKGROUND: There has been an increase in incidence and prevalence of inflammatory bowel disease (IBD) outside the western countries. Treatment costs are an essential component for healthcare planning and priority setting. The utilization patterns and annual administration and cost of IBD medication...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cost Eff Resour Alloc
Autors principals: AlRuthia, Yazed, Alharbi, Othman, Aljebreen, Abdulrahman M., Azzam, Nahla A., Almadi, Majid A., Bahari, Ohud H., Almalki, Khalid A., Atham, Abdulaziz T., Alanazi, Ahmed S., Saeed, Maria, HajkhderMullaissa, Baraa, Alsenaidy, Mohammad, Balkhi, Bander
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6894268/
https://ncbi.nlm.nih.gov/pubmed/31827409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-019-0194-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars